Gabelli Healthcare & WellnessRx Trust (GRX)
9.75
-0.04
(-0.41%)
USD |
NYSE |
May 23, 10:23
GRX Total Return Level: 14.53 for May 22, 2024
Total Return Level Chart
Historical Total Return Level Data
Date | Value |
---|---|
May 22, 2024 | 14.53 |
May 21, 2024 | 14.53 |
May 20, 2024 | 14.51 |
May 17, 2024 | 14.55 |
May 16, 2024 | 14.67 |
May 15, 2024 | 14.70 |
May 14, 2024 | 14.44 |
May 13, 2024 | 14.44 |
May 10, 2024 | 14.47 |
May 09, 2024 | 14.38 |
May 08, 2024 | 14.22 |
May 07, 2024 | 14.27 |
May 06, 2024 | 14.10 |
May 03, 2024 | 14.09 |
May 02, 2024 | 14.00 |
May 01, 2024 | 13.95 |
April 30, 2024 | 13.97 |
April 29, 2024 | 14.00 |
April 26, 2024 | 13.99 |
April 25, 2024 | 14.08 |
April 24, 2024 | 14.22 |
April 23, 2024 | 14.31 |
April 22, 2024 | 14.09 |
April 19, 2024 | 13.86 |
April 18, 2024 | 13.72 |
Date | Value |
---|---|
April 17, 2024 | 13.79 |
April 16, 2024 | 13.81 |
April 15, 2024 | 13.85 |
April 12, 2024 | 13.88 |
April 11, 2024 | 14.25 |
April 10, 2024 | 14.40 |
April 09, 2024 | 14.58 |
April 08, 2024 | 14.55 |
April 05, 2024 | 14.62 |
April 04, 2024 | 14.52 |
April 03, 2024 | 14.64 |
April 02, 2024 | 14.70 |
April 01, 2024 | 14.99 |
March 28, 2024 | 15.20 |
March 27, 2024 | 15.14 |
March 26, 2024 | 14.92 |
March 25, 2024 | 14.84 |
March 22, 2024 | 14.86 |
March 21, 2024 | 14.86 |
March 20, 2024 | 14.73 |
March 19, 2024 | 14.70 |
March 18, 2024 | 14.52 |
March 15, 2024 | 14.56 |
March 14, 2024 | 14.64 |
March 13, 2024 | 14.79 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
8.414
Minimum
Mar 23 2020
17.51
Maximum
Jan 03 2022
13.77
Average
13.77
Median
Dec 22 2022
Total Return Level Benchmarks
Simplify Health Care ETF | 30.35 |
Invesco Pharmaceuticals ETF | 100.96 |
SPDR® S&P Pharmaceuticals ETF | 55.98 |
Tekla Healthcare Opportunities Fund | 42.65 |
abrdn Life Sciences Investors | 194.17 |